Abstract
Perfusion during cardiopulmonary bypass with low-dose heparin (activated clotting time, > 180 sec) versus full-dose heparin (activated clotting time, > 480 sec) combined with high-dose aprotinin was evaluated prospectively. Fifteen patients undergoing elective myocardial revascularization were randomly assigned to 1 of 2 groups. No significant differences between the groups were found for age, sex, body surface area, preoperative hematocrit level, duration of cardiopulmonary bypass, aortic cross-clamp time, mean number of bypasses per patient, or mean number of arterial grafts per patient. In all patients, heparin-coated cardiopulmonary bypass equipment was used, including heparinized hollow-fiber membrane oxygenators and tubing sets. In each group, protamine sulfate was given equivalent to the heparin loading dose; additional doses were administered according to the ACT. The mean total dosage of heparin was 9.5 +/- 1.4 x 10(3) IU for the group given low systemic heparinization (Group 1) compared with 34.6 +/- 3.4 x 10(3) IU for the group given full systemic heparinization in combination with high-dose aprotinin (Group 2) (p < 0.0001). The mean amount of aprotinin administered in Group 2 was 5.6 +/- 0.3 x 10(6) KIU; aprotinin was not used in Group 1. The mean protamine dosage necessary in Group 1, 7.0 +/- 0.9 x 10(3) IU, was significantly less than the 22.9 +/- 3.2 x 10(3) IU needed in Group 2 (p < 0.0001). In Group 1, shed blood recovery was achieved by a red-cell spinning device; in Group 2, cardiotomy suction was used. The total chest tube drainage (i.e., postoperative blood loss) per patient in Group 1 totaled 432 +/- 162 mL/m2; in Group 2, it was 311 +/- 111 mL/m2 (difference not significant). Transfusion requirements comprised a mean volume of 143 +/- 165 mL/m2 concentrated homologous red blood cells per patient in Group 1 and 416 +/- 128 mL/m2 in Group 2 (p < 0.01). Heparin-coated perfusion equipment allowed a significantly lower dosage of systemic heparin and protamine in Group 1 than that in Group 2, and a lower dosage in Group 2 than that in previous studies. Postoperative blood loss appeared to be similar between groups. The combination of heparin-coated perfusion equipment with low systemic heparinization and a red-cell spinning device provides promising results.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carrel T., Bauer E., Laske A., von Segesser L., Turina M. Low-dose aprotinin also allows reduction of blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991 Nov;102(5):801–802. [PubMed] [Google Scholar]
- Fraedrich G., Weber C., Bernard C., Hettwer A., Schlosser V. Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin--preliminary results. Thorac Cardiovasc Surg. 1989 Apr;37(2):89–91. doi: 10.1055/s-2007-1013914. [DOI] [PubMed] [Google Scholar]
- Harder M. P., Eijsman L., Roozendaal K. J., van Oeveren W., Wildevuur C. R. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. Ann Thorac Surg. 1991 Jun;51(6):936–941. doi: 10.1016/0003-4975(91)91009-k. [DOI] [PubMed] [Google Scholar]
- Royston D., Bidstrup B. P., Taylor K. M., Sapsford R. N. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987 Dec 5;2(8571):1289–1291. doi: 10.1016/s0140-6736(87)91190-1. [DOI] [PubMed] [Google Scholar]
- von Segesser K., Turina M. Long term cardiopulmonary bypass without systemic heparinization. Int J Artif Organs. 1990 Oct;13(10):687–691. [PubMed] [Google Scholar]
- von Segesser L. K., Lachat M., Leskosek B., Turina M., Gallino A., von Felten A., Pei P. Cardiopulmonary bypass with low systemic heparinization: an experimental study. Perfusion. 1990;5(4):267–276. doi: 10.1177/026765919000500405. [DOI] [PubMed] [Google Scholar]
- von Segesser L. K., Weiss B. M., Garcia E., Gallino A., Turina M. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization. Eur J Cardiothorac Surg. 1990;4(12):639–643. doi: 10.1016/1010-7940(90)90054-4. [DOI] [PubMed] [Google Scholar]
- von Segesser L. K., Weiss B. M., Garcia E., von Felten A., Turina M. I. Reduction and elimination of systemic heparinization during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1992 Apr;103(4):790–799. [PubMed] [Google Scholar]
- von Segesser L. K., Weiss B. M., Pasic M., Leskosek B., von Felten A., Pei P., Turina M. Experimental evaluation of heparin-coated cardiopulmonary bypass equipment with low systemic heparinization and high-dose aprotinin. Thorac Cardiovasc Surg. 1991 Oct;39(5):251–256. doi: 10.1055/s-2007-1019981. [DOI] [PubMed] [Google Scholar]